http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106309456-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106309456-B |
| titleOfInvention | Application of the ginsenoside in the preparation of anti-phosphatide body syndrome molecular targeted therapy |
| abstract | Application of the ginsenoside in the preparation of anti-phosphatide body syndrome molecular targeted therapy.The present invention relates to ginsenoside pharmaceutical field application.More particularly to the application in the preparation of anti-phosphatide body syndrome molecular targeted therapy.In the anti-phosphatide body syndrome mouse model of laboratory, such compound can effectively reduce anticardiolipin antibodies in blood, anti-β 2 GP1 antibody and lupus anticoagulant are horizontal；Simultaneously in pregnant mouse model, such compound effectively reduces aCL activation, partial thromboplastin time, platelet count and abortion ratio；Safety research shows that such compound is safe, does not influence central nervous system, cardiovascular system and respiratory system, no mutagenesis.Show that there is such compound higher safety and confrontation phosphatide body syndrome to have good inhibiting effect under test dose, can be used for the treatment of anti-phosphatide body syndrome. |
| priorityDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.